Regeneron Pharmaceuticals Inc

Lobbying Transparency and Governance

Sign up to access all our data and the evidence and analysis underlying our overall scores. Once you've created an account, we'll get in touch with further details:

Lobbying Governance
Overall Assessment Analysis Score
Limited Regeneron indicates that it participates in trade association policy discussions, noting that "Regeneron has a representative on the trade association committee responsible for climate policy and engages actively in association policy deliberations to the extent they occur within the association." However, the company does not disclose any formal governance process for aligning either its direct or indirect lobbying with its climate strategy, including any periodic review or board-level sign-off, and it does not identify a specific individual or internal body to oversee such activities. The absence of a public commitment or position to conduct engagement in line with the goals of the Paris Agreement is made clear by the statement, "No, and we do not plan to have one in the next two years," and we found no evidence of a broader policy or monitoring mechanism for climate lobbying alignment.

View Sources

1
Lobbying Transparency
Overall Assessment Analysis Score
Limited Regeneron Pharmaceuticals provides only limited insight into its climate-policy lobbying. It notes that it takes part in the Biotechnology Innovation Organization and that its employees sit on association committees, indicating an indirect lobbying channel through trade-association participation, but it offers no information on direct meetings, letters, or other engagement tools, nor does it identify the government bodies those associations approach. The company does not name any specific climate-related bills, regulations, or policy proposals it has tried to influence, and it gives no explanation of the positions or policy outcomes it aims to secure through its involvement. As a result, while the disclosure confirms that some form of climate-policy engagement may occur via industry groups, it leaves stakeholders without meaningful detail on what policies are at issue, how the company seeks to shape them, or to what end.

1